Who We Are
From next-generation biologics to advanced materials, breakthrough science is pushing boundaries every day. But in order for innovations to make in impact, they need to flow. Literally.
Viscosity determines how liquids flow, behave, and perform — shaping what’s possible in everything from life-saving drugs to industrial formulations. When viscosity gets in the way, even the most promising breakthroughs can stall.
That’s where we come in.
We solve viscosity problems so innovators can bring their best ideas to life — faster, more efficiently, and with fewer trade-offs.
Today, we’re focused on next-generation pharmaceuticals, where viscosity challenges can make or break billion-dollar pipelines. But the science we’re building applies across industries, wherever viscosity stands between innovation and impact.
What We Do
We design and execute experiments using proprietary methods, patented technologies, and an automated facility featuring high-throughput and microscale capabilities.
The right combination of molecules can unlock surprising synergistic changes in viscosity. We apply screening methods to uncover synergies that others miss. Every formulation has a sweet spot. We find it.
We start where you are—whether that means engineering your formulation from the ground up or refining what already exists.
If you’re developing a product and viscosity is standing in the way, we should talk.
What Makes Us Special
We’ve tackled viscosity challenges across a wide range of industries including antimicrobial coatings, food preservatives, and injectable biologic medications.
Through these experiences, we’ve built a living library of excipient interactions, uncovering how ingredients work together to alter viscosity by finding synergies no one has mapped before.
If there’s one thing we’ve learned, it’s that viscosity rarely has an easy answer. The way molecules interact isn’t always obvious, and traditional trial-and-error approaches fall short.
Join us as we build something better.
What We Deliver
Solutions for Complex Problems
Chemicals are tailored to fit your needs, whether that means generally regarded as safe (GRAS), FDA-approved, antimicrobial, or injectable.
We are experts at exploring whole landscapes of viscosity options, giving you flexibility for manufacturing, regulatory needs, and compatibility.
Microscale Experiments
AEMS Corp is outfitted with state-of-the-art instruments that can keep solution volumes as low as 20 uL per experiment.
Research and development campaigns are designed from the ground up to use a minimal amount of your precious formulation or chemical cargo.
Speed
Our lab is capable of running 600+ experiments each week using an integrated and automated pipeline.
We offer accelerated research plans to suit your specific needs.
Our Areas of Expertise
Injectable biologics
High-concentration biologics exhibit increased viscosity that can make it difficult to adapt into subcutaneous injection devices.
Our viscosity reduction platform enables smoother delivery and broader formulation possibilities. While we specialize in siRNA therapeutics, our approach extends to other biologics, small molecules, and even non-pharmaceutical applications.
Sprayable coatings
Sprayable coatings must be engineered to balance viscosity, curing time, hardness, transparency, adhesion, and shelf life—all while maintaining consistent performance and ease of application.
We formulate coatings that achieve optimal flow properties for smooth, uniform application for antimicrobial surfaces and next-generation functional coatings.
Developing novel systems
We engineer molecular systems from the ground up, defining the fundamental rules and interactions that drive performance, stability, and scalability.
For example, we developed Agent Delivery Matrix (ADM) as an antimicrobial and edible sprayable coating—to provide safe and effective pathogen protection in food applications.
How We Can Help
REVIVE STALLED PROGRAMS
When viscosity challenges halt drug development, promising therapies can get stuck before reaching patients. We help companies overcome these barriers, optimizing formulations to ensure drugs move forward through clinical trials and into the market.
dE-rISK EARLY DEVELOPMENT
Early formulation decisions—like choosing subcutaneous vs. intravenous delivery—are often made with limited data when minimal drug substance is available. We provide early-stage viscosity insights, helping companies make informed choices before locking into costly, less-preferred pathways.
Accelerate product pipelines
Speed alone isn’t enough—knowing where to focus is what drives real progress. Our proprietary formulation expertise and trade-secret methods help companies bypass inefficient trial-and-error, accelerating development with smarter, targeted viscosity solutions that others can’t replicate.
Explore chemical space
Even simple formulations can create unexpected complexity, making it difficult to predict how ingredients interact. Our expertise in chemical space mapping allows us to efficiently navigate these unknowns, unlocking new formulation possibilities and breakthrough product innovations.
Leadership
W. Scott Compel, PHD
Chief Executive Officer
Co-Founder
Scott is a chemist turned materials engineer who enjoys creating innovative new material platforms, ranging from nanomaterials to 3D printed carbon fiber composites. As a leader, Scott fosters collaboration and mutual respect by attending to the needs of his colleagues, focusing on building trust and honest communication. As someone that has benefited greatly from excellent mentors, Scott is committed to paying it forward by mentoring young scientists and entrepreneurs. Outside the lab, Scott enjoys picking up new hobbies and getting bored of them fairly quickly - the only surviving hobbies are woodworking, cooking, and mountain biking. His love for skiing is unfortunately dwarfed by his hatred of traffic.
Alexander R. Hendricks, PhD
Chief Innovation Officer
Co-Founder
Alex is happiest when diving into something new and challenging. Whether he's crafting narratives around scientific concepts, strategizing for business growth, or exploring fresh ideas in marketing, he thrives on navigating unfamiliar territory. Though he often defaults to being a listener, Alex is known among friends to be an extreme devil’s advocate; not to be difficult (so he says), but for the joy of exploring ideas from every angle. Outside of work, he enjoys painting, creative writing, rebuilding cars, and exercise. Above all, Alex is approachable and open-minded, always ready to listen thoughtfully and respond with respect.
Advisors
Michael Chang
Capture.HK
Nick Traggis
Ambrosia Biosciences
Nick Colella
Incubic
Milton Chang
Incubic
Partnerships
At AEMS Corp, we believe in the transformative power of collaboration. We have established partnerships with world-renowned experts who share our vision of enhancing biotechnology and making it more accessible and convenient for all. We are actively seeking additional partners to combine our knowledge and resources in tackling the industry's most pressing challenges. Together, we aim to deliver cutting-edge solutions that make a lasting impact. Join us as we forge a path toward a brighter, more equitable future alongside our esteemed partners.
Whether you need a quick win or a long-term partner to rethink how your whole pipeline handles viscosity, we’re built to work the way you need us to.
Press
Featured
Contact Us
